NCT00973115View on ClinicalTrials.gov

Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Hyperlipidemia
Interventions
DRUG

Simvastatin CR

Trial Locations (1)

Unknown

8 Sites, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT00973115 - Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter